Bloomberg:GETIB@SS

Getinge Interim Report July-September 2024: Strong order intake but temporary delivery disruptions had a negative impact on earnings

GOTHENBURG, Sweden, Oct. 18, 2024 /PRNewswire/ -- "The order intake increased by 10.0%, of which organic growth was 7.4%. All regions reported a positive performance," says Mattias Perjos, President & CEO at Getinge. The medtech company's net sales increased by 3.5%, of which the organic increase...

2024-10-18 14:42 1395

Getinge to acquire Paragonix Technologies, a growth leader in the organ transplantation market

Today, Getinge announces an agreement to acquire 100% of Paragonix Technologies, Inc., a leading organ transport products and services company in the United States for an aggregated purchase price, including upfront and earn out payments, estimated to approximatelyUSD 477 million. GOTHENBURG, Swe...

2024-08-23 05:00 2657

Getinge's financial target 2024-2028: Adjusted EPS growth of above 12% on average

GOTHENBURG, Sweden, May 15, 2024 /PRNewswire/ -- Getinge updates its financial target for adjusted EPS growth 2024-2028 to be above 12% on average. The target takes into account today's decisions (see below) that follow from the letter that the U.S. Food and Drug Administration (FDA) sent to heal...

2024-05-15 02:52 1770

Getinge Interim Report January-March 2022: Healthy order book but supply chain challenges

GOTHENBURG, Sweden, April 26, 2022 /PRNewswire/ -- "Net sales declined by 6.4% and the order intake fell organically by 4.4% in the quarter," says Mattias Perjos, President & CEO. "However, excluding the strong sales of ventilators in 2021, we had organic growth in both order intake and net sales...

2022-04-26 14:26 1763

Getinge Year End Report 2021: "Healthy order growth, improved EBITA margin and strong cash flow"

GOTHENBURG, Sweden, Jan. 28, 2022 /PRNewswire/ -- "The organic order intake increased 6.4% in the fourth quarter following growth in all business areas and regions", says Mattias Perjos, President & CEO at Getinge. "Excluding currency effects, our order bookings are more than 20% larger compared ...

2022-01-28 15:14 5435

Getinge accelerates growth and productivity to reach new financial targets

GOTHENBURG, Sweden, Nov. 22, 2021 /PRNewswire/ -- "Getinge's new financial targets for 2022-2025, an annual organic net sales growth of 4-6% and adjusted EPS growth of above 10% on average throughout the period, is well in line with our strategy and ambitions", says Mattias Perjos, President & CE...

2021-11-22 21:50 1611

Getinge Q3 Report 2021: "Strong order intake and our remediation measures completed in Germany"

GOTHENBURG, Sweden, Oct. 20, 2021 /PRNewswire/ -- "Organic order intake increased by more than 20% in the third quarter, with a strong performance in all business areas and regions," says Mattias Perjos, President & CEO at Getinge. "Our cash flow remains strong, meaning that we have strengthened ...

2021-10-20 15:19 3413

Getinge Interim Report January-June 2021: Strong recovery in products for surgery

GETINGE, Sweden, July 16, 2021 /PRNewswire/ -- "In total, sales increased by 3.6% organically compared with the second quarter 2020, and the order intake declined by 6.1% organically compared with 2020 when we received very large orders of advanced ICU ventilators", says Mattias Perjos, President...

2021-07-16 14:36 37960

Getinge introduces a long-term flexible workplace approach

GOTHENBURG, Sweden, March 29, 2021 /PRNewswire/ -- Three out of four Getinge employees who have worked from home during the COVID-19 pandemic believe that the setup has improved their productivity as well as their work-life harmony. As a result, the company is introducing a long-term flexible wor...

2021-03-29 15:40 3040

Getinge launches NICCI - the latest innovation in Advanced Hemodynamic Monitoring

- NICCI is Getinge's latest innovation in Advanced Hemodynamic Monitoring, providing continuous and noninvasive hemodynamic insights to reduce the risk of severe complications for patients with low blood pressure GOTHENBURG, Sweden, Oct. 26, 2020 /PRNewswire/ -- Blood pressure is one of the most...

2020-10-26 21:34 3590

The ventilation technology from Getinge that is groundbreaking both for premature babies and adults

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- Born 12 weeks too early with a 50/50 chance at survival,Sabina Checketts has grown up to become a neonatal doctor herself, using new therapies and sophisticated technology to improve outcomes for premature babies. One such technique called NAVA, ...

2020-09-30 21:51 14313

Independent multi-center trial shows that Getinge's NAVA ventilation mode shortens time of mechanical ventilation by almost 35% for adult ICU patients

GOTHENBURG, Sweden, Sept. 30, 2020 /PRNewswire/ -- The clinical effectiveness of Getinge's patented Neurally Adjusted Ventilatory Assist (NAVA), which uses the patient's own respiratory drive to control ventilator assistance, is supported in the NAVIATOR trial. According to the NAVIATOR trial, N...

2020-09-30 21:45 14188

Getinge and partners showcase connectivity solutions for the quiet ICU of the future

GOTHENBURG, Sweden, Sept. 9, 2020 /PRNewswire/ -- Together with leading industry partners, Getinge is showcasing innovative connectivity solutions for creating a more quiet and healing environment for the intensive care unit (ICU). By distributing audible alarms outside patient rooms, ICUs will b...

2020-09-09 21:01 2634

Getinge Interim Report January-June 2020: Making a Real Difference Together With our Customers

GOTHENBURG, Sweden, July 16, 2020 /PRNewswire/ -- "During this year's second quarter, we report a continued strong order intake and net sales of advanced ICU ventilators and ECMO therapy products for hospitals and Sterile Transfer products for the pharmaceutical industry," says Mattias Perjos, Pr...

2020-07-16 14:19 9740

Getinge Interim Report for January-March 2020: Intense Efforts to Help Hospitals in the COVID-19 Pandemic

GOTHENBURG, Sweden, April 22, 2020 /PRNewswire/ -- "The quarter was dominated by the COVID-19 pandemic and the huge need for advanced ventilators and ECMO therapy at intensive care units around the world. Our leading global positions in these fields contributed to a 47% organic order growth, says...

2020-04-22 14:37 5853

Getinge Online improves uptime in the Operating Room

Gothenburg, Sweden, April 16, 2020 /PRNewswire/ -- Today Getinge introduces one of its latest connectivity solutions for acute care products. The digital platform Getinge Online enables hospitals to improve efficiency by using product data to gain insights and maximize uptime. Of the acute care p...

2020-04-16 21:53 7160

Getinge to Further Increase Production Capacity of Ventilators in 2020

GOTHENBURG, Sweden, April 6, 2020 /PRNewswire/ -- Getinge, the world market leader in advanced ventilators for intensive care units, is announcing yet another ramp-up in production capacity, to 26,000 ventilators in 2020. The increase equals a growth of 160% compared to 2019, when 10,000 ventilat...

2020-04-06 22:17 4306

Getinge and WaterAid Partner up to Strengthen Access to Clean Water, Sanitation and Hygiene at Health Care Facilities Around the World

GOTHENBURG, Sweden, April 3, 2020 /PRNewswire/ -- Today Getinge announces a partnership with the international organization WaterAid. Their joint effort aim at contributing in the important work to ensure availability and sustainable management of clean water, sanitation and hygiene in health car...

2020-04-03 16:57 6652

Getinge Increases Production Capacity of Ventilators with 60% to Support the Needs of Global Intensive Care Units

GOTHENBURG, Sweden, March 18, 2020 /PRNewswire/ -- Getinge has since the outbreak of the COVID-19 pandemic seen an increased global demand for ventilators, extra corporeal life support (ECLS) equipment and advanced monitoring for Intensive Care Units. To meet the global demand Getinge will tempo...

2020-03-18 01:32 6508

Getinge to Acquire Applikon Biotechnology B.V., A Leading Company in the Fast Growing Area of Bioreactor Systems

GOTHENBURG, Sweden, Dec. 19, 2019 /PRNewswire/ -- Getinge announces today an agreement to acquire 100% of the shares in Applikon Biotechnology B.V. from Applikon Biotechnology Holding B.V. Applikon Biotechnology B.V. is a leading company in the fast growing area of advanced bioreactor systems for...

2019-12-19 18:27 15216
12